Jared Kushner’s Firm Left a $32 Million Defense Stake Out of Its SEC Filing
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Affinity Partners, the investment firm Jared Kushner founded, reported its Arxis (NASDAQ:ARXS) shares late. Its second-quarter Form 13F, filed August 14, 2026, did not list Arxis. An amendment filed November 5 added 689,411 Arxis Class A shares worth $31,809,424 as of June 30.
A Form 13F is the quarterly holdings report that large investment managers file with the SEC within 45 days of quarter end. An amendment that adds holdings means the original was incomplete. This amendment came two days after the November 3 midterm elections.
Arxis closed Friday, November 20, 2026, at $48.46. That was down 5.94% on the day and 9.06% for the week. Nothing in the trading data links the fall to the filings.
Kushner works as an envoy on Gaza, Iran, and Russia’s war in Ukraine. Arxis supplies parts for the F-35, Navy destroyers, nuclear submarines, and missile defense. However, the stake is small and gives Affinity no control.
What the Filings Actually Show
The August filing listed only one other company’s shares, in two lines totaling $565.0 million. The amendment names Affinity Partners Fund I Co-Invest GP LP as the other manager on the Arxis position.
Affinity’s third-quarter 13F, filed November 16, lists the same shares at $34,050,009 as of September 30. Its reported total is $449.8 million.
The shares were reportedly bought after President Trump returned to the White House, but the filings do not say when Affinity bought them or what it paid. Affinity and Kushner did not answer requests for comment, and no one has explained the gap.
House Oversight Committee ranking member Robert Garcia sent Kushner a records-preservation letter on November 18. It went out the day the gap was first reported. The letter does not say any wrongdoing over Arxis.
Why the Stake Barely Registers at Arxis
By 24/7 Wall St. estimates, Affinity’s shares were worth about $33.4 million at Friday’s close. That is about 0.16% of Arxis’s shares. Arcline Investment Management funds hold 98.7% of the voting power, so Affinity has no say in how Arxis is run.
The filings do not show that Kushner’s diplomatic work shaped the investment, and for Arxis shareholders, the open question concerns Affinity’s disclosure and has no effect on Arxis’s operations.
Defense and Space programs made up about 47% of Arxis’s 2025 revenue and 46% of its first-half 2026 revenue. Total 2025 revenue was about $1.6 billion.
Arcline’s Control Is the Bigger Risk
Third-quarter revenue rose 36%[1] to $563.979 million, with 29% organic growth. Adjusted EBITDA margin (operating profit before interest, taxes, depreciation and amortization, excluding one-time items) reached 45.4%[1].
However, Arxis is a controlled company, so outside holders cannot shape its board. Arcline could also sell shares in later sales, and that added supply could weigh on the stock.
What Arxis Investors Should Track Next
Arxis’s operating outlook stands apart from the Affinity filings. Management raised its 2026 revenue guidance to $2,050 million to $2,070 million[1] and set 2027 revenue guidance at $2,400 million to $2,500 million.
The stock trades between its 52-week low of $33.15 and its high of $61.50. It is up 25.06% from its first-day close on April 16, 2026. The weekly drop leaves this growing defense supplier below its peak.
Affinity’s fourth-quarter 13F, due within 45 days of December 31, will show whether it still holds the stake. A bigger test is Arxis’s fourth-quarter report. Revenue for 2026 below the raised $2,050 million[1] floor would matter more for the stock than any Kushner headline. Arcline’s control and the chance of more share sales could limit gains even if results keep beating expectations.
Contact [email protected] for any questions or corrections.








